Clinical Trials for JCR Pharmaceuticals

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: JCR Pharmaceuticals

Clinical Trials (6)

NCT06488924
An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB
PHASE1/PHASE2Recruiting
10 participants
Started: Nov 5, 2024 · Completed: Apr 30, 2030
1 condition1 sponsor3 locations
NCT06095388
Phase I/II Study of JR-441 in Patients With Mucopolysaccharidosis Type IIIA
PHASE1/PHASE2Active, not recruiting
15 participants
Started: Oct 4, 2023 · Completed: Oct 31, 2029
1 condition1 sponsor1 location
NCT05594992
An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in MPS II (Hunter Syndrome) Subjects
PHASE3Enrolling by invitation
80 participants
Started: Feb 22, 2023 · Completed: Feb 28, 2028
1 condition1 sponsor9 locations
NCT04573023
A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)
PHASE3Active, not recruiting
86 participants
Started: Feb 14, 2022 · Completed: Oct 31, 2027
1 condition1 sponsor29 locations
NCT04348136
An Extension Study of JR-141 in Patients With Mucopolysaccharidosis Type II
PHASE2/PHASE3Active, not recruiting
27 participants
Started: Sep 1, 2019 · Completed: Mar 31, 2030
1 condition1 sponsor20 locations
NCT03708965
An Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis II
PHASE2Active, not recruiting
19 participants
Started: Jan 1, 2019 · Completed: Dec 31, 2027
1 condition1 sponsor2 locations